1. INTRODUCTION 1.1. REPORT DESCRIPTION 1.2. RESEARCH METHODOLOGY 1.2.1 SECONDARY RESEARCH 1.2.2 DATA ANALYSIS FRAMEWORK 1.2.3 MARKET SIZE ESTIMATION 1.2.4 FORECASTING 1.2.5 PRIMARY RESEARCH AND DATA VALIDATION 2. MARKET SNAPSHOT, 2019-2030 MILLION USD 2.1. MARKET SNAPSHOT 3. PORTER’S FIVE FORCE MODEL ANALYSIS 4. MARKET DYNAMICS 4.1. GROWTH DRIVERS 4.1.1 DRIVER 1 4.1.2 DRIVER 2 4.1.3 DRIVER 3 4.1.4 DRIVER 4 4.2. CHALLENGES 4.2.1 CHALLENGE 1 4.2.2 CHALLENGE 2 4.3. OPPORTUNITIES 4.3.1 OPPORTUNITY 1 4.3.2 OPPORTUNITY 2 5. GLOBAL CANCER VACCINES MARKET, BY TECHNOLOGY 5.1. OVERVIEW 5.2. DENDRITIC CELLS (DC) CANCER VACCINES 5.2.1 DENDRITIC CELLS (DC) CANCER VACCINES MARKET, BY REGION 5.2.1.1 North America Dendritic Cells (DC) Cancer Vaccines Market, By Country 5.2.1.2 Europe Dendritic Cells (DC) Cancer Vaccines Market, By Country 5.2.1.3 Asia-Pacific Dendritic Cells (DC) Cancer Vaccines Market, By Country 5.2.1.4 RoW Dendritic Cells (DC) Cancer Vaccines Market, By Country 5.3. RECOMBINANT CANCER VACCINES 5.3.1 RECOMBINANT CANCER VACCINES MARKET, BY REGION 5.3.1.1 North America Recombinant Cancer Vaccines Market, By Country 5.3.1.2 Europe Recombinant Cancer Vaccines Market, By Country 5.3.1.3 Asia-Pacific Recombinant Cancer Vaccines Market, By Country 5.3.1.4 RoW Recombinant Cancer Vaccines Market, By Country 5.4. ANTIGEN/ADJUVENT CANCER VACCINES 5.4.1 ANTIGEN/ADJUVENT CANCER VACCINES MARKET, BY REGION 5.4.1.1 North America Antigen/Adjuvent Cancer Vaccines Market, By Country 5.4.1.2 Europe Antigen/Adjuvent Cancer Vaccines Market, By Country 5.4.1.3 Asia-Pacific Antigen/Adjuvent Cancer Vaccines Market, By Country 5.4.1.4 RoW Antigen/Adjuvent Cancer Vaccines Market, By Country 5.5. VIRAL VECTOR AND DNA CANCER VACCINES 5.5.1 VIRAL VECTOR AND DNA CANCER VACCINES MARKET, BY REGION 5.5.1.1 North America Viral Vector and DNA Cancer Vaccines Market, By Country 5.5.1.2 Europe Viral Vector and DNA Cancer Vaccines Market, By Country 5.5.1.3 Asia-Pacific Viral Vector and DNA Cancer Vaccines Market, By Country 5.5.1.4 RoW Viral Vector and DNA Cancer Vaccines Market, By Country 6. GLOBAL CANCER VACCINES MARKET, BY TYPE 6.1. OVERVIEW 6.2. PREVENTIVE CANCER VACCINES 6.2.1 PREVENTIVE CANCER VACCINES MARKET, BY REGION 6.2.1.1 North America Preventive Cancer Vaccines Market, By Country 6.2.1.2 Europe Preventive Cancer Vaccines Market, By Country 6.2.1.3 Asia-Pacific Preventive Cancer Vaccines Market, By Country 6.2.1.4 RoW Preventive Cancer Vaccines Market, By Country 6.3. THERAPEUTIC CANCER VACCINES 6.3.1 THERAPEUTIC CANCER VACCINES MARKET, BY REGION 6.3.1.1 North America Therapeutic Cancer Vaccines Market, By Country 6.3.1.2 Europe Therapeutic Cancer Vaccines Market, By Country 6.3.1.3 Asia-Pacific Therapeutic Cancer Vaccines Market, By Country 6.3.1.4 RoW Therapeutic Cancer Vaccines Market, By Country 7. GLOBAL CANCER VACCINES MARKET, BY INDICATION 7.1. OVERVIEW 7.2. CERVICAL CANCER 7.2.1 CERVICAL CANCER MARKET, BY REGION 7.2.1.1 North America Cervical Cancer Market, By Country 7.2.1.2 Europe Cervical Cancer Market, By Country 7.2.1.3 Asia-Pacific Cervical Cancer Market, By Country 7.2.1.4 RoW Cervical Cancer Market, By Country 7.3. PROSTATE CANCER 7.3.1 PROSTATE CANCER MARKET, BY REGION 7.3.1.1 North America Prostate Cancer Market, By Country 7.3.1.2 Europe Prostate Cancer Market, By Country 7.3.1.3 Asia-Pacific Prostate Cancer Market, By Country 7.3.1.4 RoW Prostate Cancer Market, By Country 7.4. OTHER INDICATIONS 7.4.1 OTHER INDICATIONS MARKET, BY REGION 7.4.1.1 North America Other Indications Market, By Country 7.4.1.2 Europe Other Indications Market, By Country 7.4.1.3 Asia-Pacific Other Indications Market, By Country 7.4.1.4 RoW Other Indications Market, By Country 8. GLOBAL CANCER VACCINES MARKET, BY END USER 8.1. OVERVIEW 8.2. PEDIATRICS 8.2.1 PEDIATRICS MARKET, BY REGION 8.2.1.1 North America Pediatrics Market, By Country 8.2.1.2 Europe Pediatrics Market, By Country 8.2.1.3 Asia-Pacific Pediatrics Market, By Country 8.2.1.4 RoW Pediatrics Market, By Country 8.3. ADULTS 8.3.1 ADULTS MARKET, BY REGION 8.3.1.1 North America Adults Market, By Country 8.3.1.2 Europe Adults Market, By Country 8.3.1.3 Asia-Pacific Adults Market, By Country 8.3.1.4 RoW Adults Market, By Country 9. GLOBAL CANCER VACCINES MARKET, BY REGION 9.1. OVERVIEW 9.2. NORTH AMERICA 9.2.1 NORTH AMERICA CANCER VACCINES MARKET, BY TECHNOLOGY 9.2.2 NORTH AMERICA CANCER VACCINES MARKET, BY TYPE 9.2.3 NORTH AMERICA CANCER VACCINES MARKET, BY INDICATION 9.2.4 NORTH AMERICA CANCER VACCINES MARKET, BY END USER 9.2.5 NORTH AMERICA CANCER VACCINES, MARKET BY COUNTRY 9.2.5.1 U.S. 9.2.5.1.1 U.S. Cancer Vaccines Market, By Technology 9.2.5.1.2 U.S. Cancer Vaccines Market, By Type 9.2.5.1.3 U.S. Cancer Vaccines Market, By Indication 9.2.5.1.4 U.S. Cancer Vaccines Market, By End User 9.2.5.2 Canada 9.2.5.2.1 Canada Cancer Vaccines Market, By Technology 9.2.5.2.2 Canada Cancer Vaccines Market, By Type 9.2.5.2.3 Canada Cancer Vaccines Market, By Indication 9.2.5.2.4 Canada Cancer Vaccines Market, By End User 9.2.5.3 Mexico 9.2.5.3.1 Mexico Cancer Vaccines Market, By Technology 9.2.5.3.2 Mexico Cancer Vaccines Market, By Type 9.2.5.3.3 Mexico Cancer Vaccines Market, By Indication 9.2.5.3.4 Mexico Cancer Vaccines Market, By End User 9.3. EUROPE 9.3.1 EUROPE CANCER VACCINES MARKET, BY TECHNOLOGY 9.3.2 EUROPE CANCER VACCINES MARKET, BY TYPE 9.3.3 EUROPE CANCER VACCINES MARKET, BY INDICATION 9.3.4 EUROPE CANCER VACCINES MARKET, BY END USER 9.3.5 EUROPE CANCER VACCINES, MARKET BY COUNTRY 9.3.5.1 Germany 9.3.5.1.1 Germany Cancer Vaccines Market, By Technology 9.3.5.1.2 Germany Cancer Vaccines Market, By Type 9.3.5.1.3 Germany Cancer Vaccines Market, By Indication 9.3.5.1.4 Germany Cancer Vaccines Market, By End User 9.3.5.2 UK 9.3.5.2.1 UK Cancer Vaccines Market, By Technology 9.3.5.2.2 UK Cancer Vaccines Market, By Type 9.3.5.2.3 UK Cancer Vaccines Market, By Indication 9.3.5.2.4 UK Cancer Vaccines Market, By End User 9.3.5.3 France 9.3.5.3.1 France Cancer Vaccines Market, By Technology 9.3.5.3.2 France Cancer Vaccines Market, By Type 9.3.5.3.3 France Cancer Vaccines Market, By Indication 9.3.5.3.4 France Cancer Vaccines Market, By End User 9.3.5.4 Italy 9.3.5.4.1 Italy Cancer Vaccines Market, By Technology 9.3.5.4.2 Italy Cancer Vaccines Market, By Type 9.3.5.4.3 Italy Cancer Vaccines Market, By Indication 9.3.5.4.4 Italy Cancer Vaccines Market, By End User 9.3.5.5 Rest of Europe 9.3.5.5.1 Rest of Europe Cancer Vaccines Market, By Technology 9.3.5.5.2 Rest of Europe Cancer Vaccines Market, By Type 9.3.5.5.3 Rest of Europe Cancer Vaccines Market, By Indication 9.3.5.5.4 Rest of Europe Cancer Vaccines Market, By End User 9.4. ASIA-PACIFIC 9.4.1 ASIA-PACIFIC CANCER VACCINES MARKET, BY TECHNOLOGY 9.4.2 ASIA-PACIFIC CANCER VACCINES MARKET, BY TYPE 9.4.3 ASIA-PACIFIC CANCER VACCINES MARKET, BY INDICATION 9.4.4 ASIA-PACIFIC CANCER VACCINES MARKET, BY END USER 9.4.5 ASIA-PACIFIC CANCER VACCINES, MARKET BY COUNTRY 9.4.5.1 China 9.4.5.1.1 China Cancer Vaccines Market, By Technology 9.4.5.1.2 China Cancer Vaccines Market, By Type 9.4.5.1.3 China Cancer Vaccines Market, By Indication 9.4.5.1.4 China Cancer Vaccines Market, By End User 9.4.5.2 India 9.4.5.2.1 India Cancer Vaccines Market, By Technology 9.4.5.2.2 India Cancer Vaccines Market, By Type 9.4.5.2.3 India Cancer Vaccines Market, By Indication 9.4.5.2.4 India Cancer Vaccines Market, By End User 9.4.5.3 Japan 9.4.5.3.1 Japan Cancer Vaccines Market, By Technology 9.4.5.3.2 Japan Cancer Vaccines Market, By Type 9.4.5.3.3 Japan Cancer Vaccines Market, By Indication 9.4.5.3.4 Japan Cancer Vaccines Market, By End User 9.4.5.4 Australia 9.4.5.4.1 Australia Cancer Vaccines Market, By Technology 9.4.5.4.2 Australia Cancer Vaccines Market, By Type 9.4.5.4.3 Australia Cancer Vaccines Market, By Indication 9.4.5.4.4 Australia Cancer Vaccines Market, By End User 9.4.5.5 Rest of Asia-Pacific 9.4.5.5.1 Rest of Asia-Pacific Cancer Vaccines Market, By Technology 9.4.5.5.2 Rest of Asia-Pacific Cancer Vaccines Market, By Type 9.4.5.5.3 Rest of Asia-Pacific Cancer Vaccines Market, By Indication 9.4.5.5.4 Rest of Asia-Pacific Cancer Vaccines Market, By End User 9.5. ROW 9.5.1 ROW CANCER VACCINES MARKET, BY TECHNOLOGY 9.5.2 ROW CANCER VACCINES MARKET, BY TYPE 9.5.3 ROW CANCER VACCINES MARKET, BY INDICATION 9.5.4 ROW CANCER VACCINES MARKET, BY END USER 9.5.5 ROW CANCER VACCINES, MARKET BY COUNTRY 9.5.5.1 Brazil 9.5.5.1.1 Brazil Cancer Vaccines Market, By Technology 9.5.5.1.2 Brazil Cancer Vaccines Market, By Type 9.5.5.1.3 Brazil Cancer Vaccines Market, By Indication 9.5.5.1.4 Brazil Cancer Vaccines Market, By End User 9.5.5.2 Argentina 9.5.5.2.1 Argentina Cancer Vaccines Market, By Technology 9.5.5.2.2 Argentina Cancer Vaccines Market, By Type 9.5.5.2.3 Argentina Cancer Vaccines Market, By Indication 9.5.5.2.4 Argentina Cancer Vaccines Market, By End User 9.5.5.3 Turkey 9.5.5.3.1 Turkey Cancer Vaccines Market, By Technology 9.5.5.3.2 Turkey Cancer Vaccines Market, By Type 9.5.5.3.3 Turkey Cancer Vaccines Market, By Indication 9.5.5.3.4 Turkey Cancer Vaccines Market, By End User 9.5.5.4 South Africa 9.5.5.4.1 South Africa Cancer Vaccines Market, By Technology 9.5.5.4.2 South Africa Cancer Vaccines Market, By Type 9.5.5.4.3 South Africa Cancer Vaccines Market, By Indication 9.5.5.4.4 South Africa Cancer Vaccines Market, By End User 9.5.5.5 Rest of RoW 9.5.5.5.1 Rest of RoW Cancer Vaccines Market, By Technology 9.5.5.5.2 Rest of RoW Cancer Vaccines Market, By Type 9.5.5.5.3 Rest of RoW Cancer Vaccines Market, By Indication 9.5.5.5.4 Rest of RoW Cancer Vaccines Market, By End User 10. COMPANY PROFILES 10.1. ADVAXIS INC. 10.1.1 COMPANY OVERVIEW 10.1.2 COMPANY SNAPSHOT 10.1.3 OPERATING BUSINESS SEGMENTS 10.1.4 PRODUCT PORTFOLIO 10.1.5 BUSINESS PERFORMANCE 10.1.6 KEY STRATEGIC MOVES AND DEVELOPMENT 10.2. AMGEN INC. 10.2.1 COMPANY OVERVIEW 10.2.2 COMPANY SNAPSHOT 10.2.3 OPERATING BUSINESS SEGMENTS 10.2.4 PRODUCT PORTFOLIO 10.2.5 BUSINESS PERFORMANCE 10.2.6 KEY STRATEGIC MOVES AND DEVELOPMENT 10.3. DYNAVAX TECHNOLOGIES CORPORATION 10.3.1 COMPANY OVERVIEW 10.3.2 COMPANY SNAPSHOT 10.3.3 OPERATING BUSINESS SEGMENTS 10.3.4 PRODUCT PORTFOLIO 10.3.5 BUSINESS PERFORMANCE 10.3.6 KEY STRATEGIC MOVES AND DEVELOPMENT 10.4. GENEREX BIOTECHNOLOGY CORPORATION 10.4.1 COMPANY OVERVIEW 10.4.2 COMPANY SNAPSHOT 10.4.3 OPERATING BUSINESS SEGMENTS 10.4.4 PRODUCT PORTFOLIO 10.4.5 BUSINESS PERFORMANCE 10.4.6 KEY STRATEGIC MOVES AND DEVELOPMENT 10.5. GLAXOSMITHKLINE PLC (GSK) 10.5.1 COMPANY OVERVIEW 10.5.2 COMPANY SNAPSHOT 10.5.3 OPERATING BUSINESS SEGMENTS 10.5.4 PRODUCT PORTFOLIO 10.5.5 BUSINESS PERFORMANCE 10.5.6 KEY STRATEGIC MOVES AND DEVELOPMENT 10.6. IMMUNOCELLULAR THERAPEUTICS, LTD 10.6.1 COMPANY OVERVIEW 10.6.2 COMPANY SNAPSHOT 10.6.3 OPERATING BUSINESS SEGMENTS 10.6.4 PRODUCT PORTFOLIO 10.6.5 BUSINESS PERFORMANCE 10.6.6 KEY STRATEGIC MOVES AND DEVELOPMENT 10.7. MERCK & CO., INC. 10.7.1 COMPANY OVERVIEW 10.7.2 COMPANY SNAPSHOT 10.7.3 OPERATING BUSINESS SEGMENTS 10.7.4 PRODUCT PORTFOLIO 10.7.5 BUSINESS PERFORMANCE 10.7.6 KEY STRATEGIC MOVES AND DEVELOPMENT 10.8. SANPOWER GROUP CO. LTD. (DENDEREON CORPORATION) 10.8.1 COMPANY OVERVIEW 10.8.2 COMPANY SNAPSHOT 10.8.3 OPERATING BUSINESS SEGMENTS 10.8.4 PRODUCT PORTFOLIO 10.8.5 BUSINESS PERFORMANCE 10.8.6 KEY STRATEGIC MOVES AND DEVELOPMENT 10.9. UBIVAC 10.9.1 COMPANY OVERVIEW 10.9.2 COMPANY SNAPSHOT 10.9.3 OPERATING BUSINESS SEGMENTS 10.9.4 PRODUCT PORTFOLIO 10.9.5 BUSINESS PERFORMANCE 10.9.6 KEY STRATEGIC MOVES AND DEVELOPMENT 10.10. VACCINOGEN, INC. 10.10.1 COMPANY OVERVIEW 10.10.2 COMPANY SNAPSHOT 10.10.3 OPERATING BUSINESS SEGMENTS 10.10.4 PRODUCT PORTFOLIO 10.10.5 BUSINESS PERFORMANCE 10.10.6 KEY STRATEGIC MOVES AND DEVELOPMENT